Clinical Trials Browser

Phase 2 × Withdrawn × 3-Iodobenzylguanidine × Clear all

NCT04831567 2022-05-19

MIBNET

Phase 2 Withdrawn

Neuroendocrine Tumors

NCT00389766 2013-07-10

High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma

Phase 2 Withdrawn

Neuroblastoma